Sichuan Cancer Hospital And Research Institute

This phase II trial is testing whether a novel radiation technique called spatially fractionated radiotherapy (SFRT), which delivers alternating high and low doses inside the tumor, can work together with the immunotherapy drug tislelizumab and standard chemotherapy to shrink lar…

This phase 2 trial tests whether combining the immunotherapy drug tislelizumab with standard chemotherapy and a targeted chemo-blocking procedure (BACE) can shrink advanced, inoperable stage III non-small cell lung cancer enough to allow surgery. About 39 participants will receiv…

This study will test whether a special type of MRI, called IVIM-MRI, can predict lymphovascular invasion (LVI) in rectal cancer patients before surgery. LVI is a sign that the cancer may spread, and knowing this ahead of time could help doctors choose the best treatment. The stud…

This study tests whether a modified version of Baduanjin, a gentle qigong exercise, is safe and helpful for people with colorectal cancer who have an ostomy. 258 participants will either do Baduanjin or walk five times a week for 12 weeks. Researchers will measure sleep quality, …

This study looks at how adults with lung nodules that might be cancer make decisions about their care before a final diagnosis. Researchers will use questionnaires to measure patients' confidence, doubts, and satisfaction with their choices. The goal is to find out what factors h…